Prelude Therapeutics, Inc. (PRLD)
3.48
-0.26
(-6.95%)
USD |
NASDAQ |
Oct 13, 11:20
Prelude Therapeutics Total Return Level : 3.74 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 3.74 |
| October 09, 2026 | 3.89 |
| October 08, 2026 | 3.88 |
| October 07, 2026 | 3.83 |
| October 06, 2026 | 3.81 |
| October 05, 2026 | 3.77 |
| October 02, 2026 | 3.67 |
| October 01, 2026 | 3.79 |
| September 30, 2026 | 3.91 |
| September 29, 2026 | 3.96 |
| September 28, 2026 | 3.91 |
| September 25, 2026 | 3.875 |
| September 24, 2026 | 3.99 |
| September 23, 2026 | 4.31 |
| September 22, 2026 | 4.85 |
| September 21, 2026 | 4.70 |
| September 18, 2026 | 4.87 |
| September 17, 2026 | 4.57 |
| September 16, 2026 | 4.47 |
| September 15, 2026 | 4.52 |
| September 14, 2026 | 4.59 |
| September 11, 2026 | 4.59 |
| September 10, 2026 | 4.67 |
| September 09, 2026 | 5.09 |
| September 08, 2026 | 5.30 |
| Date | Value |
|---|---|
| September 04, 2026 | 5.46 |
| September 03, 2026 | 5.25 |
| September 02, 2026 | 5.43 |
| September 01, 2026 | 5.49 |
| August 31, 2026 | 5.60 |
| August 28, 2026 | 5.47 |
| August 27, 2026 | 6.34 |
| August 26, 2026 | 6.56 |
| August 25, 2026 | 6.59 |
| August 24, 2026 | 6.47 |
| August 21, 2026 | 6.63 |
| August 20, 2026 | 6.50 |
| August 19, 2026 | 5.78 |
| August 18, 2026 | 5.75 |
| August 17, 2026 | 5.63 |
| August 14, 2026 | 5.55 |
| August 13, 2026 | 5.36 |
| August 12, 2026 | 5.73 |
| August 11, 2026 | 5.32 |
| August 10, 2026 | 4.83 |
| August 07, 2026 | 4.90 |
| August 06, 2026 | 4.68 |
| August 05, 2026 | 4.54 |
| August 04, 2026 | 4.52 |
| August 03, 2026 | 4.39 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Q32 Bio, Inc. | 8.74 |
| Intellia Therapeutics, Inc. | 12.58 |
| Twist Bioscience Corp. | 151.86 |
| Beam Therapeutics, Inc. | 25.13 |
| Revolution Medicines, Inc. | 193.95 |